Can novel delivery help Zynerba steal a march on cannabis giant GW?

marijuana_cannabis_cbd_thc_big

If it were ever doubted that cannabis-based therapies would one day occupy space in certain specialists’ armamentaria, that time has now certainly passed.

Asked whether a failure to take such therapies seriously had led to institutional resistance, Zynerba Pharmaceuticals (Nasdaq :ZYNE) chief executive Armando Anido tells The Pharma Letter: "If we had tried to do this five or six years ago, we would have seen more of that.”

He adds: “I give GW some credit because they've been at it for more than twenty years, and they blazed a path in this area. By showing data that the drug works, it helps get investors comfortable that it’s not mumbo-jumbo medicine."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical